Report3 August 2020
Access Accelerated Publishes Year 3 Report
Access Accelerated is proud to launch its Year 3 report, chronicling our collective efforts in 2019 to advance access to NCD prevention, treatment and care in low- and middle-income countries.
In our first three years, Access Accelerated made tremendous progress. We informed local and global health policies, accelerated investment in health systems and advanced strong partnerships across the public and private sectors. Year 3 marked an important point in our journey, as we positioned our partners to scale solutions in supply chain, digital health and primary care. From advocating for the meaningful involvement of people living with NCDs to working with country government partners to support policy and decision-making, we listened intently and worked collaboratively to foster sustainable solutions.
Our work in 2019 wouldn’t be possible without our 27 member companies and five implementing partners — the World Bank Group, City Cancer Challenge, NCD Alliance, PATH and World Heart Federation. Together, we are setting a new standard for public-private partnerships and continually evolving to address the needs of people living with NCDs.
Today, as our world faces the unexpected impacts of COVID-19, these needs have changed. In the words of our member companies in our annual Letter from the CEOs, “As we start our fourth year in the context of the unprecedented COVID-19 crisis, Access Accelerated will continue to lead by example, building on successes and learning from setbacks, and working to mitigate the pandemic’s impact on people living with NCDs.”
In Year 4, Access Accelerated is building from the strong foundation laid in 2019 to not only continue our work toward UN Sustainable Development Goals 3.4, 3.8 and 17, but also support COVID-19 response. Meaningful collaborations are needed now more than ever before. This Year 3 report illustrates the great impact we can make when we work together to foster strong, resilient health systems that can meet the demands of infectious and chronic diseases alike.
Click here to read the report.
IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.
We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.
To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.